Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics

Justyna Romer1, Tom Curran

  • 1Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. stysia.romer@stjude.org

Cancer Research
|June 17, 2005
PubMed

Insights

A new study shows that inhibiting the Sonic Hedgehog signaling pathway can shrink medulloblastoma tumors in mice. This finding offers hope for new treatments for this common pediatric brain cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Medulloblastoma is the most common malignant pediatric brain tumor.
  • Current treatments for medulloblastoma are unsatisfactory.
  • The Sonic Hedgehog (SHH) signaling pathway is implicated in medulloblastoma development.

Purpose of the Study:

  • To investigate the therapeutic potential of targeting the Sonic Hedgehog pathway in medulloblastoma.
  • To evaluate the efficacy of a small-molecule inhibitor of SHH signaling in a preclinical model.

Main Methods:

  • Utilized a transgenic mouse model of medulloblastoma.
  • Administered a small-molecule inhibitor targeting the Sonic Hedgehog pathway.
  • Monitored tumor regression and assessed pathway activity.

Main Results:

  • The small-molecule inhibitor effectively regressed medulloblastoma tumors in the mouse model.
  • Inhibition of the Sonic Hedgehog pathway demonstrated significant anti-tumor activity.
  • Successful targeting of the SHH pathway offers a potential therapeutic strategy.

Conclusions:

  • Inhibitors of the Sonic Hedgehog signaling pathway show promise as a novel treatment for medulloblastoma.
  • Targeting the SHH pathway may be an effective strategy for treating certain malignancies.
  • Further research into SHH pathway inhibitors is warranted for pediatric brain tumors.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...